JPRN-UMIN000038103已完成未知
Sodium-glucose cotransporter 2 inhibition reduces body weight but not plasma glucose level in patients with type2 diabetes and mild renal failure - Sodium-glucose cotransporter 2 inhibition reduces body weight but not plasma glucose level in patients with type2 diabetes and mild renal failure
Manda Memorial Hospital0 个研究点目标入组 80 人开始时间: 2019年9月26日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 85years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients suspected of having secondary diabetes (ex. endocrine disease, drug-induced or liver disease) 2) Females who are pregnant or who intend to become pregnant within the study 3) Severe hepatic disease, malignancy, a history of gastrectomy and/or positive for HIV 4) Contraindication with SGLT2 inhibitors 5) Patient who disqualified from the study by the investigator for any reason other than given above.
研究者
相似试验
已完成
不适用
Effects of sodium-glucose co-transporter 2 inhibitor on metabolic parameters in patients with diabetes mellitusType 2 diabetesJPRN-UMIN000021584agoya University150
已完成
1 期
Effects of sodium glucose co-transporter-2 inhibitor on atrial arrhythmia burden in patient with cardiovascular implantable electronic device: a randomized controlled trialAtrial fibrillation in patients with cardiac implantable electronic deviceTCTR20210315003Faculty of Medicine, Chiang Mai University166
尚未招募
3 期
A clinical trial to study the effect of a drug,dapagliflozin in type 2 diabetic mellitus patient having diabetic macular edemaCTRI/2019/03/017915Postgraduate Institute of Medical Education and Research
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA
已完成
不适用
Effect of Sodium-Glucose Cotransporter-2 inhibitor in patients with type 2 daibetes mellitusJPRN-UMIN000014168Jichi Medical University82